RIKEN GENESIS

RIKEN GENESIS

Specializes in promotion of personalized medicine based on contract analysis of next-generation sequencing and exomes.

Launch date
Employees
Market cap
-
Enterprise valuation
CAD160—239m (Dealroom.co estimates Jun 2014.)
Tokyo Japan (HQ)
  • Edit
DateInvestorsAmountRound

$29.3m

Early VC
Total FundingCAD39.9m

Recent News about RIKEN GENESIS

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.